Dividend logo
  • STOCK
  • SHPG
  • PRICE AS OF: Jan 04, 07:34 PM EDT
  • $179.20 +$7.05 +4.1%
  • INDUSTRY
  • Drug manufacturers - major
i
Shire plc (SHPG) either stopped trading, was acquired or changed ticker symbols. You can still view historical stock and dividend information for Shire plc by scrolling below.

SHPG
Stock Dividend Data

DIVIDEND
YIELD
?
?

0.00%
Healthcare Average 0.60%

ANNUALIZED
PAYOUT
?

$0.00
 

PAYOUT
RATIO
?

0.0%
EPS $15.27

DIVIDEND
GROWTH
?

6 yrs
Since 2013

SHPG
Daily Snapshot

PRICE

$179.20

QUOTE TIME

Jan 04, 07:34 PM

TODAY'S VOLUME

5,316,900

OPEN PRICE

$176.60

DAY'S RANGE

$175.71 - $181.22

PREVIOUS CLOSE

$172.15

52 WEEK LOW / HIGH

$123.73 - $182.47

PERCENT OFF 52 WEEK HIGH

-1.79%

SHPG
Upcoming Dividend Payouts

SHPG has not yet officially announced its next dividend payout.

Capture Shire plc Dividend with Much Less Risk

Analyze over 2 ETFs with Significant Exposure to SHPG

SHPG
Dividend.com DARS Rating™ Breakdown for SHPG

Sign Up
Metric SHPG Rank Healthcare Avg. Ranking Notes
Relative Strength
Overall Yield Attractiveness
Dividend Reliability
Dividend Uptrend
Earnings Growth
DARS Rating

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks

SHPG
Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2018
Consecutive
Years of
Increases
14.9% 14.9% 6 years
Unlock Dividend Growth History

SHPG
Research

SHPG
Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
2018
2017
2016
Unlock Historical Annual Dividend Data & Growth
Download Historical Dividend Data for SHPG in .XLS

Brought to You by Mitre Media

SHPG
Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$0.1680 2018-09-06 2018-09-07 2018-10-19 Unknown Regular Semi Annual
$0.8937 2018-03-08 2018-03-09 2018-04-24 Unknown Regular Semi Annual
$0.1527 2017-09-07 2017-09-08 2017-10-20 Unknown Regular Semi Annual
$0.7710 2017-03-08 2017-03-10 2017-04-25 Unknown Regular Semi Annual
$0.1389 2016-09-07 2016-09-09 2016-10-07 Unknown Regular Semi Annual
$0.6648 2016-03-09 2016-03-11 2016-04-12 Unknown Regular Semi Annual
$0.1263 2015-09-02 2015-09-04 2015-10-02 Unknown Regular Semi Annual
$0.5727 2015-03-11 2015-03-13 2015-04-14 Unknown Regular Semi Annual
$0.1149 2014-09-03 2014-09-05 2014-10-03 Unknown Regular Semi Annual
$0.5079 2014-03-05 2014-03-07 2014-04-08 Unknown Regular Semi Annual
$0.0900 2013-09-04 2013-09-06 2013-10-03 Unknown Regular Semi Annual
$0.4380 2013-03-06 2013-03-08 2013-04-09 Unknown Regular Semi Annual
$0.0819 2012-09-05 2012-09-07 2012-10-04 Unknown Regular Semi Annual
$0.3777 2012-03-07 2012-03-09 2012-04-12 Unknown Regular Semi Annual
$0.0744 2011-09-09 Unknown Regular Semi Annual
$0.3255 2011-03-09 2011-03-11 2011-04-07 Unknown Regular Semi Annual
$0.0675 2010-09-08 2010-09-10 2010-10-07 Unknown Regular Semi Annual
$0.2775 2010-03-10 2010-03-12 2010-04-14 Unknown Regular Semi Annual
$0.0644 2009-09-09 2009-09-11 2009-10-08 Unknown Regular Semi Annual
$0.2328 2009-03-11 2009-03-13 2009-04-08 Unknown Regular Semi Annual
$0.0644 2008-09-10 2008-09-12 2008-10-09 Unknown Regular Semi Annual

SHPG
Investor Resources

Learn more about Shire plc on:

Company Website For more information, visit the company website.
Investor Relations Here you can find contact information on how to get in touch with the company.
Wiki Page Visit the company page on Wikipedia.
SEC Filings Get access to filings such as 8-K, 10-K, 13-D, Proxy Statements and more.

SHPG
Company Profile

Exchange: NASDAQ
Sector: Healthcare

Shire PLC- (SHPGY)-focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

© 2019 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.